Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
METARON is a natural extract-based nutraceutical developed by AronPharma, specifically designed to support blood glucose management in individuals with diabetes or metabolic concerns. The formulation is characterized by a high concentration of polyphenolic compounds, which are bioactive plant metabolites known for their antioxidant properties and their role in regulating carbohydrate metabolism. METARON aims to provide a supportive nutritional intervention to help maintain healthy glycemic levels and improve overall metabolic health. It is currently part of AronPharma's research and development pipeline, leveraging standardized plant extracts to address metabolic disorders.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on METARON.